General Anaesthesia
1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
B. BraunPropofol
Stimit AGElectromagnetic stimulation
Stimit AGElectromagnetic stimulation
AmbuAmbu Aura Gain supraglottic airway
Clinical Trials (4)
Total enrollment: 294 patients across 4 trials
Efficacy and Safety Study of Two Propofol Formulations
Start: Jun 2007Est. completion: Oct 2007220 patients
Phase 3Completed
Electromagnetic Stimulation of the Phrenic Nerve of Intubated Patients With Obesity
Start: Dec 2021Est. completion: Apr 20225 patients
N/ACompleted
Electromagnetic Stimulation of the Phrenic Nerve of Intubated Patients
Start: Jul 2021Est. completion: Jul 20215 patients
N/ACompleted
Comparing Between Air-Q Intubating Laryngeal Airway and Ambu® AuraGain™
Start: Nov 2016Est. completion: Jun 201864 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.